Last updated on May 2020

Nivolumab With Gemcitabine Oxaliplatin + Rituximab in r/r Elderly Lymphoma Patients


Brief description of study

This study evaluates the addition of nivolumab to gemcitabine, oxaliplatin plus rituximab in case of B-cell lymphoma

Detailed Study Description

International, multicentre, randomised, open-label, treatment optimisation study, preceded by safety run-in phases conducted for B-cell and T-cell lymphoma separately.

Clinical Study Identifier: NCT03366272

Find a site near you

Start Over

Institut de Canc rologie Lucien Neuwirth

Saint-Priest-en-Jarez, France
0.01miles
  Connect »

Institut de Canc rologie Lucien Neuwirth

Saint-Priest-en-Jarez, France
0.39miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.